Latest filing published 09 Nov 2026 for CTS CORP.
Insider track record
Kimberly Banks MacKay: trading record in brief
This profile gathers the share dealings of Kimberly Banks MacKay across 2 companies, led by West Pharmaceutical Services Inc and CTS Corp. We count 6 filings; the first trade dates from 22 February 2022 and the latest from 5 November 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 9 November 2026 with a share grant in CTS Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kimberly Banks MacKay
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,813 shares0Common StockSEC:0000026058-26-000045:0
- 92.69 shares@ US$211.007.1% of flowCommon StockSEC:0001127602-25-006120:1
- 246.162 shares@ US$211.0020.3% of flowCommon StockSEC:0001127602-25-006120:0
- 720 shares0Common StockSEC:0001127602-24-006398:0
- 327 shares@ US$306.6838.4% of flowCommon StockSEC:0001562180-23-001795:0
- 310 shares@ US$369.1341.4% of flowCommon StockSEC:0001562180-22-001901:0
6 of 6 declarations
